The National Center for Testing Treatments in Chronic Spinal Cord and Traumatic Brain Injury
Launched by THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER, HOUSTON · May 10, 2016
Trial Information
Current as of August 19, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Current treatment for Spinal Cord Injury and Traumatic Brain Injury focuses on stabilizing the patient and preventing secondary injury with the aim of maximizing the best chance of recovery. Most patients will show varying amounts of recovery, but, when the injury is severe, that recovery is only partial. Enrollment in the NCTT will allow for classification and characterization of injury, function, co-morbidities, secondary issues/problems, research interests and will serve as a conduit for enrollment into interventional studies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • History of spinal cord injury and/or brain injury
- • Able to provide HIPAA authorization to share prior medical records/imaging
- • Age 18 and older.
- Exclusion Criteria:
- • Life expectancy less than 6 months, vegetative state or co-existing disease or other characteristic that precludes appropriate diagnosis of spinal cord or brain injury.
- • Other condition that, in the opinion of the site investigator, would interfere with adherence to study requirements.
- • Inability or unwillingness of subject or legal guardian/representative to give informed consent (e.g., ward of the state).
About The University Of Texas Health Science Center, Houston
The University of Texas Health Science Center at Houston (UTHealth) is a leading academic institution dedicated to advancing health through education, research, and clinical practice. As a prominent sponsor of clinical trials, UTHealth leverages its extensive resources and expertise in biomedical research to facilitate innovative studies aimed at improving patient outcomes. The institution is committed to fostering a collaborative environment that promotes scientific discovery and the translation of research findings into effective healthcare solutions, all while adhering to the highest ethical standards and regulatory guidelines. With a multidisciplinary approach, UTHealth plays a critical role in addressing complex health challenges and enhancing the quality of life in diverse communities.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Georgene Hergenroeder, PhD
Principal Investigator
UTHealth
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials